Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients.

Simona SoveriniC De BenedittisC PapayannidisK Machova PolakovaC VenturiD RussoP BrescianiA IurloM ManciniA VitaleS ChiarettiR FoàE AbruzzeseF SoràA KohlmannT HaferlachM BaccaraniM CavoG Martinelli

Published in: Leukemia (2016)

Keyphrases

acute lymphoblastic leukemia
end stage renal disease
chronic myeloid leukemia
allogeneic hematopoietic stem cell transplantation
tyrosine kinase
newly diagnosed
chronic kidney disease
prognostic factors
single cell
patient reported